HIV-1 Integrase Diversity and Resistance-Associated Mutations and Polymorphisms Among Integrase Strand Transfer Inhibitor-Naive HIV-1 Patients from Cameroon

The World Health Organization (WHO) has put forth recommendations for the use of integrase (IN) strand transfer inhibitors (INSTIs) to be part of the first-line combination antiretroviral therapy regimen to treat HIV infections. The knowledge of pretreatment drug resistance against INSTIs is still s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	AIDS research and human retroviruses 2020-05, Vol.36 (5), p.450-455
Hauptverfasser:	Mikasi, Sello Given, Gichana, Josiah Otwoma, Van der Walt, Cheri, Brado, Dominik, Obasa, Adetayo Emmanuel, Njenda, Duncan, Messembe, Martha, Lyonga, Emilia, Assoumou, Okomo, Cloete, Ruben, Ikomey, George Mondinde, Jacobs, Graeme Brendon
Format:	Artikel
Sprache:	eng
Schlagworte:	AIDS/HIV Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Cameroon Cohort Studies Drug resistance Genotype HIV HIV Infections - blood HIV Infections - drug therapy HIV Infections - virology HIV Integrase - genetics HIV Integrase Inhibitors - therapeutic use HIV-1 - enzymology HIV-1 - genetics Human immunodeficiency virus Humans Integrase Medicin och hälsovetenskap Mutation Phylogeny Polymorphism, Genetic RNA, Viral - genetics Sequence Analysis, DNA
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!